Quantcast

Industry news that matters to you.  Learn more

New Study Shows Cleveland HeartLab Inflammation Testing can Prevent Thousands of Heart Attacks and Strokes, Averting $187 Million in Healthcare Costs for Cardiovascular Disease

Cleveland HeartLab Inc. (CHL), the premier cardiovascular disease management company, and MDVIP, the leader in personalized, preventive medicine, are pleased to announce the publication of a seminal peer review study in the Journal of Medical Economics. The study shows that by improving cardiovascular disease risk (CVD) assessment, CHL’s inflammation testing could reduce heart attacks and strokes by nearly 10 percent.